Introduction
============

Some athletes may abuse drugs and ergogenic substances to enhance their performances by increasing strength ([@B1], [@B2]). Anabolic-androgenic steroids (AAS) include a variety of drugs with male hormone of testosterone and its synthetic derivatives among them ([@B3]). When these drugs are taken in supraphysiologic doses, they seem to increase the athlete's muscularity, often beyond expected limits ([@B4]).

Elite athletes started to abuse AAS since the 1950s ([@B5])and currently, millions of people worldwide use AAS ([@B6]--[@B11]). Surprisingly, majority of such people are not among elites or competitive athletes, rather ordinary people who use these drugs merely to lose body fat or to gain more muscle mass ([@B12]--[@B13]). Additionally, many of AAS users also abuse other prohibited substances and drugs to look more muscular or to have a better performance ([@B14]--[@B17]).

Concerns over serious side-effects of AAS abuse such as cardiac, hepatic, neuroendocrine and psychiatric effects has increased over the last decades ([@B18]--[@B22]) and now theses drugs are considered as a big threat for public health**.** Therefore, many of researchers have focused on the predisposing risk factors for AAS abuse in order to develop an effective preventive strategy against their abuse ([@B3],[@B6],[@B7],[@B12],[@B13],[@B20]). Originally, psycho-socio-demographic factors seem to be related to AAS substance abuse; However very few authors have evaluated the effect of predisposing factors on AAS abuse among bodybuilders ([@B17], [@B23]). Some proposed psycho-socio-demographic factors such as age, job, level of education, income, purpose of participating in sporting activity, mental health and body image seem to be associated with AAS abuse ([@B3], [@B9], [@B12], [@B16], [@B17], [@B23]) though not totally consistent in the relevant literature.

In this study, we aimed to investigate the AAS abuse and its association with some psycho-socio-demographic factors among male body-builders in Tehran, Iran.

Materials and Methods
=====================

Design and setting
------------------

This study is one of few surveys in the field of substance abuse in Iran's gyms which evaluated substance abuse in 906 randomly selected male body-builders from103 randomly selected body-building clubs in Tehran, Iran.

Samples and sampling
--------------------

Between March and October 2011, 103 body-building clubs were selected based on simple random sampling method using computer-generated random numbers. Four trained research assistants went to the selected clubs in both morning and evening sessions and randomly interviewed with the predetermined number of athletes in each club (according to the club's area and number of its registered athletes). The interviews made after the completion of the exercise program and participants were invited to a silent place, usually in the gyms' buffets or trainer's room.

From these clubs, 930 body-builders who were present at the club at the time of study participated. Inclusion criteria were male gender and age of 13 to 60 years. Exclusion criteria were the subjects' request for leaving the study and lack of clear response to the questions.

Codes of ethics
---------------

Verbal consent was obtained from the athletes and they were reassured that the data would be kept strictly confidential. All participants were given information about the purpose of the study. Participants' names were not recorded to assure confidentiality. This study was conducted based on 'Ethical Principles for Medical Research involving Human Subjects' of the Helsinki Declaration and has been approved by Ethics Committee of Research Center for Substance Abuse and Dependence of Iran.

Process
-------

Data on participants' psycho-social and demographic characteristics, sporting activity patterns as well as the history of AAS abuse were collected via a 45 min interview with each participant, using structured questionnaires.

Independent variables
---------------------

Independent variables included the followings: age, average monthly family income, family size, sport experience (months), weekly duration of the sporting activity (hours), monthly cost of the sporting activity, purpose of participating in the sporting activity, and history of anabolic steroid as well as other substances use.

The purpose of participating in the sporting activity was defined by the answer to the following six options (yes/no): 1) to gain a higher social level, 2) to attract further attention, to enhance one's self-esteem, 4) to enhance one's sports performance, 5) to have a healthy life, and 6) to maintain one's fitness. Moreover, the mental health of athletes as well as their body image were assessed via General Health Questionnaire (GHQ28) and Multidimensional Body-Self Relations Questionnaire-Appearance Scales (MBSRQ-AS), respectively. The GHQ28 as a well-known popular screening tool in psychiatry has four subscales: physical symptoms, anxiety and insomnia, social dysfunction and depression. Persian version of this questionnaire had been previously validated in Iran ([@B24]). In addition, the MBSRQ-AS as a well-validated self-report inventory for the assessment of body image is a 34-item measure that consists of 5 subscales of appearance evaluation, appearance orientation, overweight preoccupation, self-classified weight, and the body areas satisfaction scale (BASS). This questionnaire had been previously validated in Iran ([@B25]).

Main outcome
------------

The main dependent variable of this survey was AAS use (self-reported data registered by face-to-face interviews). It was assessed by using the following questions: "Until now, have you ever tried any type of AAS such as testosterone, nandrolone, oxymetholone, dianabole, winstrol and other similar derivatives?"

Statistical analysis
--------------------

For this survey, a sample size of 930 was determined considering a confidence interval of 2%, for an estimated prevalence of 68% for AAS abuse according to one previous epidemiological report in Iran ([@B24]) and a total number of 30,000 athletes, based on the estimate of the Iran bodybuilding and power lifting federation. The data was analyzed using the SPSS statistical package program version 17. To compare non-normally distributed variables, the Mann-Whitney *U* test was used and the information is given as mean and standard deviation. All independent variables were inserted into a multiple logistic regression model to determine the associated factors of AAS abuse in body builders (forward selection method). Pearson's chi-squared test (χ^2^) was applied to test the difference for categorical data. The missing values in the analysis were relatively few. A *P*-value less than 0.05 were considered significant.

Results
=======

Overall, 906 agreed to participate in the study (response rate = 97.5%) with mean age (standard deviation) of 25.7 (7.1) years (Range 14-- 56), a history of AAS use was reported by 150 body-builders (16.6%). The most commonly abused AAS were nandrolone decanoate(6.1%), stanozolol (Winstrol) (3.6%), oxymetholone(3.3%), Testosterone (2.4%), dianabol (methandrostenolone) (1.9%) and dehydroepiandrostenedione(1.6%). Forty-four body-builders (4.9%) used more than one AAS (2 to 7 AAS). Cigarette smoking and alcohol consumption were reported by 148 (15.9%) and 133 (14.6%) of body-builders, respectively.

The bodybuilders who abused AAS were more prone to illegal substance abuse (23.6% vs. 15.3%,*P* = 0.015).

Until the beginning of this study, participants worked out an average of 20 months at an average of 6 h per week in bodybuilding club. They had on average monthly family income of \$631.5.

The comparison of different variables between athletes without and with AAS abuse is shown in [Table 1](#T1){ref-type="table"} and [Fig.1](#F1){ref-type="fig"}--[2](#F2){ref-type="fig"}.

###### 

Demographic characteristics in body-builders with and without history of AAS use

  **Variable**                   **Negative history of AAS abuse** [^\*^](#TFN1){ref-type="table-fn"}   **Positive history of AAS abuse**   ***P* -Value** [^\*\*^](#TFN2){ref-type="table-fn"}
  ------------------------------ ---------------------------------------------------------------------- ----------------------------------- -----------------------------------------------------
  Age (yr)                       26.04 (6.08)                                                           25.76 (7.36)                        0.21
  Family size                    3.87 (1.66)                                                            4.04 (1.57)                         0.19
  Monthly family income (\$)     646.75 (671.15)                                                        554.66 (678.98)                     0.01 [^a^](#TFN3){ref-type="table-fn"}
  Sport experience (months)      57.77 (51.08)                                                          32.46 (45.64)                       0.001 [^a^](#TFN3){ref-type="table-fn"}
  Weekly duration of sport (h)   7.37 (3.53)                                                            6.96 (3.69)                         0.10

Mean (standard deviation)

Mann-Whitney U test/

Significant difference

*P*\> 0.05 (for all variables)

![Comparison of Body image General Health Questionnaire (GHQ28) subscales between AAS users and non-users](IJPH-44-1662-g001){#F1}

*P*\> 0.05 (for all variables)

![Comparison of Multidimensional Body-Self Relations Questionnaire-Appearance (MBSRQ-AS) subscales between AAS users and non-users](IJPH-44-1662-g002){#F2}

The results of regression analysis demonstrated that among different psycho-socio-demographic factors, less family income (*P* = 0.011) and sport experience (*P* =0.001) were significant risk factors for AAS abuse in body-builders ([Table 1](#T1){ref-type="table"}). The purpose of participating in sporting activity was not associated with AAS abuse (*P*\>0.05).

Discussion
==========

Based on this study, almost one in six body-builders in Tehran reported AAS abuse.

Survey-based studies on the prevalence of drug abuse among athletes are broadly divided in to those that ask about self- use of drugs and those that seek information on perceived use by others. Results from the former type of study tend to reflect underreporting whilst those on perceived use tend to produce exaggerated claims ([@B26], [@B27]). Therefore, it is prudent to presume that the real prevalence may be much higher than the reported use in this survey. Furthermore, as body- building is a very popular sport in Iran, it means that a great net number of recreational athletes may be damaged by the harms of these drugs.

Earlier, point prevalence and life- time prevalence of AAS abuse in Iran was estimated as 10.7%--59% and 26%--100% respectively ([@B26], [@B28]). Similarly, the results of the majority of previous studies in Iran reported a higher prevalence of AAS abuse in body-builders in comparison to the findings of this study ([@B26], [@B29]). However, most of these studies were performed on either very limited samples or had a poor methodology while the sampling as well as methodology of the present study were good enough to provide an acceptable estimation of self-reported AAS abuse in Iranian recreational male body-builders. On the other hand, the findings of this study are relatively similar to the results of studies of Pessoa and Lindqvist et al., where they reported almost 20% of male power sport athletes had a history of AAS use ([@B30], [@B31]).

According to this study, among different psycho-socio-demographic parameters only monthly family income and sport experience were associated with AAS abuse. Body-builders who had lower family income reported steroid abuse more than the others did. It may be related to their difficulties to use an enriched and proper nutritional diet or to buy more expensive sport supplements or non-steroidal drugs such as growth hormone for ergogenic purposes. In addition, more experienced body-builders reported abuse less than the others did. This may reflect their improved knowledge to the adverse side effects of this drugs or the use of more advanced training programs. However, this may only indicate that experienced athletes are more cautious to report their own abuse because of legal or ethical considerations. Otherwise, this may reflect the new and dangerous trend of junior athletes who rely on ergogenic drugs for performance enhancement more than the seniors do.

In the study by Kashietal ([@B26]), the history of championship, the initiation time of bodybuilding and their knowledge about AAS side effects were associated with use of ergogenic agents. Since several kinds of supplements such as creatine were included as the ergogenic agents in Kashi's study, it is not rational to extend the findings of this survey to AAS abuse. In this study, there was no association between body image and AAS use among male body-builders though there was an association reported by several previous studies ([@B16],[@B32]--[@B34]). The majority of authors have evaluated the effect of body image on AAS use in bodybuilders using a different questionnaire to assess muscle dysmorphia disorder instead of body image ([@B32], [@B35], [@B36]). Muscle dysmorphia (MD) has been described as a male body image disorder characterized by a pathological preoccupation with muscle size. MD seems to be associated with AAS abuse among male body-builders ([@B35]--[@B37]) and a different questionnaire (muscle dysmorphia inventory-MDI) is used to assess MD in body-builders. Since there was no validated MD questionnaire in Iran, the validated Body-Self Relations Questionnaire was used which may explain why there was no association between body image with AAS use in body-builders. Moreover, in this study there was no association between mental health and AAS use among body-builders. While many researchers reported the AAS abuse as an important predisposing factor for mental health problems such as depression, anxiety and aggression ([@B13], [@B14], [@B18], [@B19], [@B38], [@B39]), very few surveys have been performed to assess the effect of mental health problems on AAS abuse in body-builders. Since the present survey was a cross sectional study, it was not expected to find a causative relationship between mental health and AAS use in bodybuilders.

Most likely, using a specific questionnaire to assess muscle dysmorphia in body-builders instead of using Multidimensional Body-Self Relations Questionnaire could have led to find the stronger relationship between body image and substance abuse in this study.

Another important finding in the present study was the association between AAS and substance abuse among male body-builders. This finding is supported by many previous surveys ([@B10], [@B12], [@B13], [@B15], [@B40]--[@B42]). Accordingly, anabolic steroids may be considered as a gateway to illegal substance abuse with more adverse effects and additional addictive properties.

Finally, it seems necessary to study and implement a comprehensive educational program for the bodybuilding society aimed to eliminate the ignorance and warn about the adverse consequences to diminish the prevalence of AAS abuse and reduce the burden of these harmful drugs on the public health ([@B43]).

Limitations
===========

There are some limitations in this study. First, the surveys like the present study by nature lend to information bias, as participants must recall their experiences or report a socially unacceptable behavior. Second, although cross sectional studies are a useful and an efficient way to obtain general information about a target population, it is difficult to assess causality. Finally, we had to use the questionnaires which were validated in Iran, so this might have led to lose some important information.

Conclusion
==========

Self-report of lifetime AAS abuse by recreational body-builders showed a relatively high prevalence in Tehran. Some psycho-socio-demographic factors seem to be associated with AAS abuse among male body-builders. The recognition of predisposing factors for AAS abuse in body-builders may be the cornerstone of providing the educational and preventive program against the drug abuse in gyms.
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